Healthcare Company Conducts Strategic Stock Repurchase Program
Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program.
Disclaimer: This article is based on information provided in a press release and other publicly available sources. It is intended for informational purposes only and should not be considered as financial or investment advice. Readers are encouraged to conduct their own research and consult with a qualified financial advisor befor…